Covalon Technologies Ltd. CVALF OTC

Covalon Technologies Ltd. (CVALF) reported total assets of $32.77M and total liabilities of $6.4M for quarter ending 2025-12-31, resulting in total equity of $26.37M.

The company held $17.86M in cash and short-term investments. Total debt stood at $3.6M, with net debt of $-14.27M. The Debt-to-Equity (D/E) ratio was 0.14 (conservative).

Current ratio is 5.69, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0.14, current ratio of 5.69 — balance sheet is strong
• MOAT (50/100) — Total assets $32.77M and equity $26.37M support the company's competitive scale
• VALUE (75/100) — Debt-to-Equity 0.14 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 68/100 with 3/7 criteria passed.